Cargando…
The ELK3-DRP1 axis determines the chemosensitivity of triple-negative breast cancer cells to CDDP by regulating mitochondrial dynamics
Triple-negative breast cancer (TNBC) is the most lethal form of breast cancer. TNBC patients have higher rates of metastasis and restricted therapy options. Although chemotherapy is the conventional treatment for TNBC, the frequent occurrence of chemoresistance significantly lowers the efficacy of t...
Autores principales: | Park, Joo Dong, Jang, Hye Jung, Choi, Seung Hee, Jo, Gae Hoon, Choi, Jin-Ho, Hwang, Sohyun, Park, Wooram, Park, Kyung-Soon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329652/ https://www.ncbi.nlm.nih.gov/pubmed/37422450 http://dx.doi.org/10.1038/s41420-023-01536-5 |
Ejemplares similares
-
ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics
por: Park, Joo Dong, et al.
Publicado: (2022) -
Functional Link between miR-200a and ELK3 Regulates the Metastatic Nature of Breast Cancer
por: Kim, Hyung-Keun, et al.
Publicado: (2020) -
Targeting claudin-4 enhances CDDP-chemosensitivity in gastric cancer
por: Nishiguchi, Yukiko, et al.
Publicado: (2019) -
ELK3-CXCL16 axis determines natural killer cell cytotoxicity via the chemotactic activity of CXCL16 in triple negative breast cancer
por: Jung, Hae-Yun, et al.
Publicado: (2023) -
Establishment of chemosensitivity tests in triple-negative and BRCA-mutated breast cancer patient-derived xenograft models
por: Park, Hyung Seok, et al.
Publicado: (2019)